These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2166253)

  • 21. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures.
    Whelton A; Miller WE; Dunne B; Hait HI; Tresznewsky ON
    J Clin Pharmacol; 1990 Dec; 30(12):1074-80. PubMed ID: 2177062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
    Maclean D
    Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents.
    Canter DA; Texter MJ; McLain RW
    J Hypertens Suppl; 1994; 12(7):S33-8. PubMed ID: 7769502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of quinapril in the elderly hypertensive patient.
    Forette B; Koen R; Vicaut E
    Am Heart J; 1992 May; 123(5):1426-32. PubMed ID: 1575170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.
    Flack JM; Yunis C; Preisser J; Holmes CB; Mensah G; McLean B; Saunders E
    Arch Intern Med; 2000 Jun; 160(12):1842-7. PubMed ID: 10871979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril.
    Palatini P; Racioppa A; Raule G; Zaninotto M; Penzo M; Pessina AC
    Clin Pharmacol Ther; 1992 Oct; 52(4):378-83. PubMed ID: 1330398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quinapril versus lisinopril in the treatment of essential hypertension in elderly patients with low blood renin].
    Rengo F; Canonico V
    Minerva Cardioangiol; 1996 Dec; 44(12):631-5. PubMed ID: 9053816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension.
    Küppers HE; Jäger BA; Luszick JH; Gräve MA; Hughes PR; Kaan EC
    J Hypertens; 1997 Jan; 15(1):93-7. PubMed ID: 9050976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA; Chang SM; Chou TC
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group.
    Canter D; Frank GJ; Knapp LE; Phelps M; Quade M; Texter M
    J Hum Hypertens; 1994 Mar; 8(3):155-62. PubMed ID: 8006914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate variability in conscious and anesthetized rats under the action of angiotensin converting enzyme inhibitors.
    Fateev MM; Sidorov AV; Grigor'eva MV; Rakov AA; Fateeva KM
    Bull Exp Biol Med; 2012 Mar; 152(5):590-4. PubMed ID: 22803141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the acute and chronic antihypertensive effects of lisinopril and enalapril assessed by ambulatory blood pressure monitoring.
    Gourlay S; McNeil J; Forbes A; McGrath B
    Clin Exp Hypertens; 1993 Jan; 15(1):71-89. PubMed ID: 8385525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of moderate to severe hypertension with ACE inhibitors.
    Goldstein RJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S29-35. PubMed ID: 1691404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.
    Pannier BE; Garabedian VG; Madonna O; Fouchard M; Darne B; Safar ME
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):775-81. PubMed ID: 1653594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.